Survival in chronic dialysis in Argentina: period 2004-2008
Abstract
We show the Kaplan-Meier (KM) survival of inident patients (01/04/2004 to 31/12/2008) to the Argentine Registry of Chronic Dialysis (CD). Follow up (N = 27 224) had a maximum of 2101 days or 69.07 months, in this period 9747 patients died and 10,319 patients stayed alive to 31/12/2009. The median survival was 47.9 months. The multivariate Cox proportional hazards model was used to determine relative risk (RR) or Hazard Ratio (HR) between each independent variable to CD incident patients. Of all the variables we analize 29 (provided they do not conflict with each other and missing cases were <25%), 19 are shown as significant predictor variables: age at admission (4.1% increased risk of death per year), the presence of: heart failure, persistent angor or previous myocardial infarction, cerebrovascular disease, peripheral vascular insufficiency, Hepatitis C virus +, cardiac arrhythmia, have received transfusions in the past 6 months, chronic lung disease, neoplasia and be a carrier of AIDS. So is diabetic nephropathy as a cause of chronic renal disease, but when adjusted for the other variables decreased from 51% (in the univariate) to 37% in the multivariate analysis. The social variables such as no incomes, substandard housing and the absence of previous nephrologic care, as lack of anti Hepatitis B virus vaccination are significant for poor prognosis. Beginning CD with a higher clearance (estimated by MDRD) is a poor prognostic sign, for each mI / min increase in the initial screening, increases the risk of death 0.1%, significantly. The only 2 significant favorable predictors proved to be the presence of hypertension at baseline and be a resident of Capital Federal. Finally we evaluated only the population starting treatment in hemodialysis (HD). It represents 97.5% of the total (26547/27224) of 2004-2008 incident patients, including temporary (non-tunneled catheter) access in multivariate Cox model for this patients. Appeared with great impact on survival: starting HD with transient access, with a RR of death at 1 year of 2.04 (104% higher). Conclusions: we identified some variables at the beginning of dialysis related with survival to year, some of them have already been identified by numerous other authors (such as comorbid factors, albumin, etc), others are related to socioeconomic factors, MDRD calculated filtrate and transitory catheter in degree of significance that are inputs to future confirmations from this study.
References
Marinovich S, Lavorato C, Celia E, Araujo JL, Bisignano L, Soratti M. Registro de pacientes en Diálisis crónica en Argentina 2004-2005. Nefrol Argent.;2008:6(1 Supl.):9.64.
Marinovich S, Lavorato C, Celia E, Araujo JL, Bisignano L, Soratti M. Trasplante renal y otras causas de egreso del Registro de pacientes en Diálisis Crónica de Argentina 2004-2005. Rev Nefrol Diál Traspl. 2009;29(1):3-12.
Marinovich S, Lavorato C, Celia E, Araujo JL, Bisignano L y Soratti M. Mortalidad según el Registro de pacientes en Diálisis Crónica de Argentina 2004-2005. Rev Nefrol Diál Traspl. 2009;29(1):13-28.
Marinovich S, Lavorato C, Celia E, Bisignano L, Soratti M, Hansen-Krogh D, et al. Registro Argentino de Diálisis Crónica 2004-2006, versión completa [Internet]. Buenos Aires: Sociedad Argentina de Nefrología, 2006. Disponible en: http://san.org.ar/2015/interesgeneral-documentos-registrodialisis.php (citado: 30/08/2011).
Marinovich S, Lavorato C, Celia E, Bisignano L, Soratti M, Hansen-Krogh D, et al. Registro Argentino de Diálisis Crónica 2007. Informe 2009 [Internet]. Disponible en: http://san.org.ar/2015/interesgeneral-documentos-registrodialisis.php (citado: 30/08/2011).
Marinovich S, Lavorato C, Celia E, Bisignano L, Soratti M, Hansen-Krogh D, et al. Registro Argentino de Diálisis Crónica 2008. Informe 2010. Nefrol Argent. 2011;9(Supl. 1):7-62; (Supl. 2):71-126.
Sistema Nacional de Información de Procuración y Trasplante de la República Argentina (SINTRA) [Internet]. Buenos Aires: INCUCAI. Disponible en: https://sintra.incucai.gov.ar/ (citado: 30/08/2011).
Johnson JG, Gore SM, Firth J. The effect of age, diabetes, and other comorbidity on survival of patients on dialysis: a systematic quantitative overview of the literature. Nephrol Dial Transplant. 1999;14:2156-64.
Keane WF, Collins AJ Influence of co-morbidity on mortality and morbidity in patients treated with hemodialysiso. Am J Kidney Dis. 1994;24:1010-18.
Nicolucci A, Cubasso D, Labbrozzi D, et al. Effect of coexistent diseases on survival of patiems undergoing dialysis. ASAIO J. 1992;38: M291-5.
Soucie JM, McClellan WM. Early death in dialysis patients: risk factors and impact on incidence and mortality rates. J Am Soc Nephrol. 1996;7:2169-75.
Estados Unidos. Renal Data System. DSRDS 2010 Annual Data Report [Internet]. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Disponible en: http://www.usrds.org/2010/pdf/v2_03.pdf (citado: 20/08/2011).
A Rosansky SJ, Clark WF, Eggers P, Glassock RJ. Initiation of dialysis at higher GFRs: is the apparent rising tide of early dialysis harmful or helpful? Kidney Int. 2009;76(3):257-61.
Hutchinson TA, Thomas DC, MacGibbon B. Predicting survival in adults with end-stage renal disease: An age equivalence index. Ann Intern Med. 1982;96:417-23.
Soucie JM, McClellan WM. Early death in dialysis patients: risk factors and impact on incidence and mortality rates. J Am Soc Nephrol. 1996;7:2169-75.
Mazzuchi N, Carbonell E, Fernández-Cean J. ESRD patients without co-morbid risk factors at the start of haemodialysis are deal as survival comparison population. Nephrol Dial Transplant. 1999;14:1091-6.
Nicolucci A, Cubasso D, Labbrozzi D, et al. Effect of coexisting diseases on survival of patients undergoing dialysis. ASAIO J. 1992;38:M291-5.
Lorenzo V, Martn M, Rufino M, Hernández D, Torres A, Ayus JC. Predialysis nephrologic care and a functioning arteriovenous fistula at entry are associated with better survival in incident hemodialysis patients: an observational cohort study. Am J Kidney Dis. 2004;43(6):999-1007.
Astor BC, Eustace JA, Powe NR, Klag MJ, Sadler JH, Fink NE, et al. Timing of nephrologist referral and arteriovenous access use: the CHOICE Study. Am J Kidney Dis. 2001;38(3):494-501.
Canadá. Canadian Institute for Health Information. Canadian Organ Replacement Register Annual Report: Treatment of End-Stage Organ Failure in Canada 2000 to 2009 [Internet]. Disponible en: www.cihi.ca/corr (citado: 30/08/2011).
Escocia. Scottish Renal Association. Scottish Renal Registry Report, 2009 [Internet]. Edinburgh, 2010. Disponible en: http://www.srr.scot.nhs.uk (citado: 30/08/2011).
Castledine C, Steenkamp R, Feest T, Tomson CRV. UK Renal Registry. 13th Annual Report (December 2010). Chapter 6: Survival and Causes of Death of UK Adult Patients on Renal Replacement Therapy in 2009: National and Centre-Specific Analyses. Nephron Clin Pract. 2011;119(suppl 2):c107–c134.
ESRD Registry Committee, Korean Society of Nephrology. Current Status of Dialysis Therapy in Korea. Korean J Intern Med. 2011;26:123-31.
van Manen JG, van Dijk PC, Stel VS, Dekker FW, Clèries M, Conte F, et al. Confounding effect of comorbidity in survival studies in patients on renal replacement therapy. Nephrol Dial Transplant. 2007;22(1):187-95.
Jager KJ, Zoccali C. Comorbidity data collection by renal registries--a remaining challenge. Nephrol Dial Transplant. 2009;24(8):2311-3.
Khan IH, Catto GR, Edward N, Fleming LW, Henderson IS, MacLeod AM. Influence of coexisting disease on survival on renal-replacement therapy. Lancet. 1993;341(8842):415-8.
Wright LE. Survival in patients with end-stage renal disease. Am J Kidney Dis. 1991;17(1):25-8.
Charlson M, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-83.
Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245-51.
Di Iorio B, Cillo N, Cirillo M, De Santo NG. Charlson Comorbidity Index is a predictor of outcomes in incident hemodialysis patients and correlates with phase angle and hospitalization. Int J Artif Organs. 2004;27(4):330-6.
Fried L, Bernardini J, Piraino B. Charlson comorbidity index as a predictor of outcomes in incident peritoneal dialysis patients. Am J Kidney Dis. 2001;37(2):337-42.
Hemmelgarn BR, Manns BJ, Quan H, Ghali WA. Adapting the Charlson Comorbidity Index for use in patients with ESRD. Am J Kidney Dis. 2003;42(1):125-32.
Fernandez Lucas M, Teruel JL, Zamora J, Lopez Mateos M, Rivera M, Ortuno J. A Mediterranean age-comorbidity prognostic index for survival in dialysis populations. J Nephrol. 2007;20(6):696-702.
Marinovich S, Lavorato C, Moriñigo C, Celia E, Bisignano L, Soratti M, et al. A new prognostic index for one-year survival in incident hemodialysis patients. Int J Artif Organs. 2010;33(10):689-99.